Several Research for New Antimicrobial Drug Development will boost the Global Cefazolin Market Growth

The global cefazolin sodium market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period (2022-2028). Several types of research for the development of antimicrobial drugs that does not get resisted by the human body are propelling the growth of the global cefazolin sodium market. For instance, the Thayer School of Engineering at Dartmouth had engineered a new bacterial agent in September 2020, for drug-resistant bacterial infections with the help of natural lysins. Similarly, the Oxford University had conducted high collaborative research in December 2021 for the discovery of a new treatment that has the ability to reverse antibiotic resistance in bacteria that causes sepsis, pneumonia, and urinary tract infections with the help of carbapenems, by producing enzymes called Metallo-beta-lactamases (MBLs) that break down the carbapenem antibiotics, stopping them from working. 

Browse the full report description “Global Cefazolin Sodium Market Size, Share & Trends Analysis Report by Type (Antimicrobial Drug, Cephalosporins, and First Generation Cephalosporins) and by End-User (Adults and Children) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/cefazolin-sodium-market 

The market players are also contributing significantly to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new vaccine launches for the advancement of the disease treatment, to stay competitive in the market. For instance, the Premier Inc. had partnered with Apotex Corp. in February 2021, to supply three major antibiotics to healthcare providers. This was done to secure the immediate and long-term supply of antibiotics medication to treat bacterial infections. 

Market Coverage

• The market number available for – 2022-2028
• Base year- 2022
• Forecast period- 2022-2028

Segment Covered- 

• By Type
• By End-User

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape - including CSPC Pharmaceutical Group Ltd., Dun& Bradstreet, Inc., HISUN USA Ltd., Pfizer Inc., LKPC Pharmaceutical Co. Ltd., and others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cefazolin Sodium Market Report Segment

By Type

• Antimicrobial Drug
• Cephalosporins
• First Generation Cephalosporins

By End-User

• Adults
• Children

Global Cefazolin Sodium Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/cefazolin-sodium-market